GEN - Genetic Engineering & Biotech NewsOriginal article
Rznomics Joins Lilly Gateway Labs to Quicken RNA Therapeutic Candidate Discovery and Development
PartnershipPositive
AI Analysis
Summary
Rznomics has joined Eli Lilly's Gateway Labs to accelerate RNA therapeutic candidate discovery and development across its database of over 200 disease targets.
Importance:5/10
Sentiment:
0.60
RNA therapeuticspartnershipLilly Gateway Labsdrug discovery
Related Companies
Read the original article
Published by GEN - Genetic Engineering & Biotech News on August 24, 2026 3:21 PM